Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation

Blood. 2002 Jul 1;100(1):356-8. doi: 10.1182/blood-2001-12-0351.

Abstract

Hydrops fetalis is rarely caused by congenital dyserythropoietic anemia (CDA). We report a patient with hydrops fetalis as a result of severe anemia. This patient needed intrauterine transfusions from 21 weeks of gestation until birth. The hematologic study showed an atypical CDA (hydrops fetalis-associated CDA) characterized by features resembling CDA type II, but negative acidified serum lysis test (HEMPAS negative). The patient was regularly transfused for a year, after which an allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling was successfully carried out. His actual hemoglobin is 127 g/L, and he has not received transfusions for more than a year. In conclusion, intrauterine transfusions and BMT could cure an otherwise lethal atypical CDA.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Dyserythropoietic, Congenital / complications*
  • Anemia, Dyserythropoietic, Congenital / therapy
  • Blood Transfusion, Intrauterine*
  • Bone Marrow Transplantation*
  • Family Health
  • Female
  • Fetal Diseases / therapy
  • Humans
  • Hydrops Fetalis / diagnosis
  • Hydrops Fetalis / etiology*
  • Hydrops Fetalis / therapy
  • Infant, Newborn
  • Male
  • Pregnancy
  • Prenatal Diagnosis
  • Transplantation, Homologous
  • Treatment Outcome